文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

孕期百日咳疫苗接种时机:证据与实施——一项系统综述

Timing of pertussis vaccination during pregnancy: Evidence and implementation - A systematic review.
PubMed 文献 · Vaccine · 2024-07-31

该系统综述检索PubMed、MEDLINE和Web of Science共1623篇文献,最终纳入45篇报告安全性、免疫原性和/或有效性的出版物,并梳理全球政府机构对孕期百日咳疫苗接种时机的推荐。结果显示接种时机可能影响免疫原性和疫苗有效性,早孕期接种后出生时免疫应答可能最佳,晚孕期接种有效性可能降低,全球推荐时机差异较大。

要点

  • 纳入的出版物未提示孕期百日咳疫苗接种时机与安全性担忧增加相关。
  • 免疫原性研究常提示早孕期接种后出生时保护可能最佳。
  • 有效性研究显示晚孕期接种较孕期较早接种疫苗有效性降低。

核心结论

  • 孕期百日咳疫苗接种时机似乎影响免疫原性和疫苗有效性,早孕期接种后出生时免疫应答可能最佳,晚孕期接种较孕期较早接种疫苗有效性可能降低。
  • 全球各国孕期百日咳疫苗接种推荐不一致且数据缺乏,反映在推荐时机的差异上。

研究设计与样本

  • 系统综述检索PubMed、MEDLINE和Web of Science,检索到1623篇文章,其中777篇为重复文献。
  • 筛选后纳入45篇出版物,报告安全性(n=11)、免疫原性(n=26)和/或有效性(n=9)。
  • 同时按推荐接种时机梳理全球政府机构对孕期百日咳疫苗的推荐。

主要发现

  • 所选出版物总体未提示孕期百日咳疫苗接种时机与安全性担忧增加相关。
  • 免疫原性研究常提示早孕期接种后出生时保护可能最佳。
  • 少数研究探讨了抗体定性特征,无研究探讨与接种时机相关的母乳抗体滴度或细胞介导免疫。
  • 有效性研究显示晚孕期百日咳疫苗接种较孕期较早接种疫苗有效性降低。
  • 全球58个国家有孕期百日咳疫苗接种一般推荐,注册的推荐时机多达22种不同时机。

关键数值与推荐

  • 纳入45篇出版物:安全性n=11、免疫原性n=26、有效性n=9。
  • 全球58个国家有孕期百日咳疫苗接种一般推荐,推荐时机多达22种。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 少数研究探讨了抗体定性特征,无研究探讨与接种时机相关的母乳抗体滴度或细胞介导免疫。
  • 数据不一致且缺乏,反映在 divergent 的国家推荐中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pertussis vaccination in pregnancy has been introduced in an increasing number of countries to better protect infants against the disease in their first weeks of life. The optimal timing of pertussis vaccination in pregnancy is however still under debate. METHODS: We systematically reviewed published literature on safety, immunogenicity and effectiveness of pertussis vaccination in pregnancy related to timing of vaccination. The search was conducted using PubMed, MEDLINE and Web of Science and yielded 1623 articles, thereof 777 duplicates. Screening resulted in the inclusion of 45 publications reporting on safety (n = 11), immunogenicity (n = 26) and/or effectiveness (n = 9). We also mapped pertussis recommendations in pregnancy by government institutions globally according to the recommended timing of vaccination. RESULTS: Overall, the selected publications did not indicate increased safety concerns associated with timing of pertussis vaccination in pregnancy. Immunogenicity studies often suggested optimal protection at birth after early third trimester vaccination. Few studies investigated qualitative antibody characteristics, and none investigated antibody titers in breastmilk or cellular-mediated immunity related to timing of vaccination. Effectiveness studies showed decreased vaccine effectiveness of late third trimester pertussis vaccination compared to vaccination earlier in pregnancy. Worldwide, a general recommendation for pertussis vaccination in pregnancy was found for 58 countries, with as many as 22 different recommended timings registered. CONCLUSION: The timing of pertussis vaccination in pregnancy seems to impact immunogenicity and vaccine effectiveness, with optimal immune responses at birth suggested following early third trimester vaccination and reduced vaccine effectiveness of late third trimester pertussis vaccination suggested compared to vaccination earlier in pregnancy. However, inconsistent and lacking data are reflected in the divergent national recommendations for pertussis vaccination in pregnancy worldwide. SUMMARY: Pertussis vaccination in pregnancy aims to protect infants in their first weeks of life. Our review suggests that immunogenicity and vaccine effectiveness are impacted by the timing of vaccination in pregnancy. National recommendations for pertussis vaccination in pregnancy vary widely worldwide.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. De Weerdt L, Herzog SA, Van Damme P, et al. Timing of pertussis vaccination during pregnancy: Evidence and implementation - A systematic review. Vaccine. 2024. PMID: 39088988. doi:10.1016/j.vaccine.2024.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。